|
6/6/2013 9:01:06 AM
|
|
|
6/5/2013 5:06:27 PM
|
Nordion Posts Q2 EPS Of $0.01 Vs. $0.05 Year Ago
|
|
5/23/2013 2:31:44 AM
|
Nordion Enters Into Agreement To Divest Targeted Therapies Business To BTG Plc
|
|
5/15/2013 4:38:38 PM
|
Nordion Signs Contract Manufacturing Agreement With Navidea Biopharmaceuticals
|
|
5/15/2013 4:34:16 PM
|
Navidea Biopharma Signs Manufacturing And Supply Agreement With Nordion
|
|
3/22/2013 11:52:27 AM
|
|
|
3/21/2013 5:13:04 PM
|
|
|
3/21/2013 5:03:26 PM
|
Nordion Settles Claims Filed By Dr. Reddy’s Laboratories; Details Confidential
|
|
3/5/2013 5:03:32 PM
|
Nordion Posts Q1 Breakeven Per Share Vs. Loss $0.01 Year Ago
|
|
1/28/2013 1:01:00 PM
|
Nordion Appoints Grant Gardiner SVP And General Counsel
|
|
1/28/2013 9:00:23 AM
|
|
|
1/21/2013 7:11:25 AM
|
Nordion Files Amended Statement Of Claim In IPFA Proceedings
|
|
10/29/2012 7:04:53 AM
|
Nordion Restructures Russian Mo-99 Supply Relationship
|
|
10/22/2012 7:05:59 AM
|
Nordion Provides Update Regarding Proceedings To Determine Potential Award Of Costs From AECL
|
|
9/12/2012 4:01:48 PM
|
Nordion Appoints Jeff Brown To Board Of Directors
|
|
9/10/2012 7:07:18 AM
|
Nordion Announces Decision In Arbitration With AECL Over Cancelled MAPLE Project
|
|
9/6/2012 9:01:50 AM
|
|
|
9/6/2012 8:48:48 AM
|
|
|
9/5/2012 4:30:56 PM
|
|
|
9/5/2012 4:14:44 PM
|
Nordion Posts Q3 Adj. Net Income Of US$15.48 Mln Or US$0.25 Per Share
|